Načítá se...
Prolonged survival with systemic chemotherapy in an advanced malignant mesothelioma: A case report
Peritoneal mesotheliomas are very rare tumors. Their prognosis is poor, average survival does not exceed 1 year after peritoneal cytoreduction. Systemic chemotherapy is considered to have no proven value in the management of peritoneal mesotheliomas. Objective responses with systemic chemotherapy ar...
Uloženo v:
| Vydáno v: | Rare Tumors |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7874336/ https://ncbi.nlm.nih.gov/pubmed/33613924 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2036361320984527 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|